Filed by Organovo Holdings, Inc.
Pursuant to Rule 425 under the Securities Act of 1933, as amended,
and deemed filed pursuant to Rule 14a-6(b) under
the Securities Exchange Act of 1934, as amended
Subject Company: Tarveda Therapeutics, Inc.
File No. of Related Registration Statement: 333-235683
Organovo Holdings, Inc.
440 Stevens Avenue, Suite 200
Solana Beach, California 92075
ADDITIONAL INFORMATION REGARDING THE SPECIAL MEETING OF STOCKHOLDERS TO BE
HELD ON THURSDAY, MARCH 26, 2020
The following Notice of Change of Location relates to the proxy statement/prospectus/information statement (the Proxy Statement)
of Organovo Holdings, Inc. (the Company), dated February 24, 2020, furnished to stockholders of the Company in connection with the solicitation of proxies by the Board of Directors of the Company for use at the Special Meeting of
Stockholders (the Special Meeting) to be held on Thursday, March 26, 2020. This Supplement is being filed with the Securities and Exchange Commission and is being made available to stockholders on or about March 16, 2020.
THE NOTICE SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT.
NOTICE OF CHANGE OF LOCATION
OF SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD ON MARCH 26, 2020
Dear
Stockholders of Organovo:
Due to the emerging public health impact of the coronavirus
outbreak (COVID-19) and to support the health and well-being of our stockholders and team members, NOTICE IS HEREBY GIVEN that the location of the Special Meeting of Stockholders of Organovo
Holdings, Inc. (the Company) has been changed. As previously announced, the Special Meeting will be held on Thursday, March 26, 2020 at 10:00 a.m., Pacific Time. In light of public health concerns regarding the coronavirus outbreak,
the Special Meeting will be held in a virtual meeting format only at www.virtualshareholdermeeting.com/ONVO2020. You will not be able to attend the Special Meeting physically.
As described in the proxy statement/prospectus/information statement for the Special Meeting previously distributed, you are entitled to participate in and
vote at the Special Meeting if you were a stockholder as of the close of business on February 14, 2020, the record date, or hold a legal proxy for the meeting provided by your bank, broker, or nominee. To be admitted to the Special Meeting
at www.virtualshareholdermeeting.com/ONVO2020, you must enter the control number found on your proxy card or voting instruction form you previously received. You may vote during the Special Meeting by following the instructions available
on the meeting website during the meeting. Whether or not you plan to attend the Special Meeting, we urge you to vote and submit your proxy in advance of the Special Meeting by one of the methods described in the proxy
statement/prospectus/information statement for the Special Meeting. The proxy card included with the proxy statement/prospectus/information statement previously distributed will not be updated to reflect the change in location and may continue to be
used to vote your shares in connection with the Special Meeting.
|
By Order of the Organovo Board of Directors,
|
|
|
Taylor Crouch
|
Chief Executive Officer
|
Solana Beach, California
|
March 16, 2020
|